Literature DB >> 944697

Synthesis and degradation of folate reductase in sensitive and methotrexate-resistant lines of S-180 cells.

F W Alt, R E Kellems, R T Schimke.   

Abstract

The methotrexate-resistant AT-3000 line of S-180 cells has at least 150-fold more immunologically cross-reactive folate reductase than sensitive cells. Highly specific immunologic and protein purification procedures were used to show that the increased enzyme levels in this line are due to a corresponding increase in the rate of folate reductase synthesis. This observation indicates that the relative turnover of the enzyme is not significantly different in the two lines. Folate reductase was purified to homogeneity from both the sensitive and the methotrexate-resistant cells. Comparison of various physical, kinetic, and immunochemical properties of the enzymes revealed no differences. These observations suggest that the AT-3000 line contains one or more regulatory variations leading to the over-production of folate reductase protein that is similar, if not identical, to that produced by sensitive cells. In resistant cells, specific immunoprecipitation experiments demonstrated that folate reductase comprises as much as 7 to 8% of the continuously labeled soluble protein and 6 to 7% of the soluble protein synthesis. Growth of these lines in the absence of methotrexate resulted in a slow decrease in the level of folate reductase to less than 1%. This decrease corresponded to a similar decrease in the relative rate of enzyme synthesis. Variations in the level of folate reductase with cell growth are also due to changes in the relative rate of enzyme synthesis. In the AT-3000 line, pulse decay experiments showed that the half-life of folate reductase was long (50 hours) relative to cell doubling time (24 hours), and also that methotrexate had little or no effect on the turnover of the enzyme. Comparison of the incorporation of radioactive leucine into folate reductase in continuous and pulse labeling experiments gave independent confirmation of these results. Therefore, the relative rate of folate reductase synthesis was the major parameter determining the amount of folate reductase under all examined conditions that resulted in altered levels of the enzyme in resistant cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 944697

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  Gene overexpression: uses, mechanisms, and interpretation.

Authors:  Gregory Prelich
Journal:  Genetics       Date:  2012-03       Impact factor: 4.562

2.  Reduced membrane protein associated with resistance of human squamous carcinoma cells to methotrexate and cis-platinum.

Authors:  S D Bernal; J A Speak; K Boeheim; A I Dreyfuss; J E Wright; B A Teicher; A Rosowsky; S W Tsao; Y C Wong
Journal:  Mol Cell Biochem       Date:  1990-06-01       Impact factor: 3.396

3.  Cytogenetical changes during early stages of development of methotrexate resistance in HeLa cells.

Authors:  J G Delinassios; M J Talieri
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

4.  Dexamethasone negatively regulates the activity of a chimeric dihydrofolate reductase/glucocorticoid receptor protein.

Authors:  D I Israel; R J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

5.  Expression of the mouse dihydrofolate reductase cDNA in B. subtilis: a system to select mutant cDNAs coding for methotrexate resistant enzymes.

Authors:  T Grange; F Kunst; J Thillet; B Ribadeau-Dumas; S Mousseron; A Hung; J Jami; R Pictet
Journal:  Nucleic Acids Res       Date:  1984-04-25       Impact factor: 16.971

6.  Chromosomal organization of the human dihydrofolate reductase genes: dispersion, selective amplification, and a novel form of polymorphism.

Authors:  N P Anagnou; S J O'Brien; T Shimada; W G Nash; M J Chen; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

7.  Amplified dihydrofolate reductase genes in unstably methotrexate-resistant cells are associated with double minute chromosomes.

Authors:  R J Kaufman; P C Brown; R T Schimke
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

8.  Variable content of double minute chromosomes is not correlated with degree of phenotype instability in methotrexate-resistant human cell lines.

Authors:  J Masters; B Keeley; H Gay; G Attardi
Journal:  Mol Cell Biol       Date:  1982-05       Impact factor: 4.272

9.  Identification of the type I trimethoprim-resistant dihydrofolate reductase specified by the Escherichia coli R-plasmid R483: comparison with procaryotic and eucaryotic dihydrofolate reductases.

Authors:  C C Simonsen; E Y Chen; A D Levinson
Journal:  J Bacteriol       Date:  1983-09       Impact factor: 3.490

10.  Networking of differentially expressed genes in human cancer cells resistant to methotrexate.

Authors:  Elisabet Selga; Carlota Oleaga; Sara Ramírez; M Cristina de Almagro; Véronique Noé; Carlos J Ciudad
Journal:  Genome Med       Date:  2009-09-04       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.